Schwetzaingen, Germany

Axel Meyer

USPTO Granted Patents = 3 



Average Co-Inventor Count = 9.0

ph-index = 1


Location History:

  • Schwetzingen, DE (2011)
  • Schwetzaingen, DE (2016 - 2018)

Company Filing History:


Years Active: 2011-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Axel Meyer: Innovator in Monoclonal Antibody Research

Introduction

Axel Meyer is a notable inventor based in Schwetzaingen, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 3 patents to his name, his work has the potential to impact medical treatments significantly.

Latest Patents

One of Axel Meyer's latest patents focuses on neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR). This invention relates to isolated proteins, specifically monoclonal antibodies that bind to the Nogo-66 receptor. These antibodies are designed to inhibit the binding of the natural ligand of the Nogo-66 receptor, effectively neutralizing its activity. The applications of these antibodies are particularly relevant for detecting NgR and inhibiting its activity in individuals suffering from disorders where NgR or Nogo-66 activity is detrimental.

Career Highlights

Throughout his career, Axel Meyer has worked with prominent companies in the biotechnology sector, including AbbVie Deutschland GmbH & Co. KG and AbbVie Inc. His experience in these organizations has allowed him to refine his expertise in monoclonal antibody research and development.

Collaborations

Axel has collaborated with notable colleagues such as Mario Mezler and Achim Moeller. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Axel Meyer stands out as an innovative inventor in the field of monoclonal antibodies, with a focus on the Nogo-66 receptor. His contributions have the potential to lead to significant advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…